Physician profile
Rina Patel
NPI 1841948759
$3,021.96
in general payments reported to CMS, 2019-2025
8 companies · $725 in 2025
The $725 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.95 · 2022: $161 · 2023: $1,924 · 2024: $171 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,459 · Food and Beverage: $1,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,459.25 |
| Food and Beverage | $1,360.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,785.88 | 2023-2025 | Ha Minuteman G3-R |
| Glaxosmithkline, LLC. | $651.57 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boston Scientific Corporation | $343.20 | 2023-2025 | General - Pain Management |
| Medtronic, INC. | $144.55 | 2024-2025 | Synchromedii, Vanta Adaptivestim, Inceptiv |
| Vertos Medical, INC. | $37.20 | 2023 | Mild Device Kit |
| Celgene Corporation | $23.36 | 2023 | Reblozyl |
| Vertex Pharmaceuticals Incorporated | $18.89 | 2025 | |
| Tersera Therapeutics LLC | $17.31 | 2023 | Prialt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rina Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.